Exelgyn
Pharmaceutical manufacturer
From Wikipedia, the free encyclopedia
Exelgyn is a French pharmaceutical company which makes and distributes the medical abortion drugs mifepristone (marketed as Mifegyne) and misoprostol.
| Industry | Pharmaceutical |
|---|---|
| Headquarters | Paris, France |
Area served | Worldwide |
| Products | mifepristone, misoprostol. |
| Website | https://exelgyn.com/ |
History
Mifepristone was originally developed by the French pharmaceutical company Roussel-Uclaf.
In 1997, after buying the remaining 43.5% of Roussel-Uclaf stock in early 1997,[1] Hoechst AG announced the end of its manufacture and sale of Mifegyne
1997, Exelgyn S.A. was founded, a single-product company immune to antiabortion boycotts, whose CEO was former Roussel-Uclaf CEO Édouard Sakiz. Hoechst AG transferred all rights for medical uses of mifepristone (outside of the United States) to Exelgyn.[2]
In 1999, Exelgyn won approval of Mifegyne in 11 additional countries.[3] As of 2024, Exelgyn distributes mifepristone to 40 countries,[4] but within the United States it is distributed by Danco Laboratories and GenBioPro.